U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases announces the availability of funding for implementation of the Multidisciplinary Studies of HIV and Viral Hepatitis Co-Infection (R21) Exploratory/Developmental Research Grant. The purpose of this grant is to fill gaps in the understanding of the pathogenic interactions between HIV and hepatitis viruses; co-morbidities associated with HIV/hepatitis virus co-infection; and the effectiveness of interferon-free, direct-acting antiviral drug regimens to treat HIV/HCV co-infection. The R21 mechanism is intended to encourage new exploratory and developmental . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | June 11, 2014

Federal Government Announces Multidisciplinary Studies of HIV and Viral Hepatitis Co-Infection (R21) Exploratory/Developmental Research Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member